MITF and melanoma: In particular, high levels of AXL in melanoma are associated with a transcriptional reprogramming that induces a switch from a proliferative to an invasive phenotype, intrinsically less sensitive to inhibition of the BRAF/MAPK pathway and characterized by low levels of MITF expression [39].